Wu H - Search Results

1

Novel Aptamer-Functionalized Nanoparticles Enhances Bone Defect Repair By Improving Stem Cell Recruitment.

Wang M, Wu H, Li Q, Yang Y, Che F, Wang G, Zhang L. Wang M, et al. Among authors: wu h. Int J Nanomedicine. 2019 Nov 6;14:8707-8724. doi: 10.2147/IJN.S223164. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31806966 Free PMC article.

2

Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics.

Wu H, Wang M, Dai B, Zhang Y, Yang Y, Li Q, Duan M, Zhang X, Wang X, Li A, Zhang L. Wu H, et al. Drug Deliv. 2017 Nov;24(1):1216-1229. doi: 10.1080/10717544.2017.1367976. Drug Deliv. 2017. PMID: 28845698 Free PMC article.

3

Analysis of the SNP rs3747333 and rs3747334 in NLGN4X gene in autism spectrum disorder: a meta-analysis.

Sun H, Yang Y, Zhang L, Wu H, Zhang H, Li H. Sun H, et al. Among authors: wu h. Ann Gen Psychiatry. 2019 May 21;18:6. doi: 10.1186/s12991-019-0227-5. eCollection 2019. Ann Gen Psychiatry. 2019. PMID: 31139237 Free PMC article.

4

SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells.

Wang M, Wu H, Duan M, Yang Y, Wang G, Che F, Liu B, He W, Li Q, Zhang L. Wang M, et al. Among authors: wu h. Life Sci. 2019 Sep 1;232:116663. doi: 10.1016/j.lfs.2019.116663. Epub 2019 Jul 16. Life Sci. 2019. PMID: 31323275

5

Corrigendum to "SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells" [Life Sci. 232 (2019) 116663].

Wang M, Wu H, Duan M, Yang Y, Wang G, Che F, Liu B, He W, Li Q, Zhang L. Wang M, et al. Among authors: wu h. Life Sci. 2020 Jan 1;240:117111. doi: 10.1016/j.lfs.2019.117111. Epub 2019 Nov 30. Life Sci. 2020. PMID: 31796206 No abstract available.

6

[Isovaleric acidemia due to compound heterozygous variants of IVD gene in a case].

Che F, Yang Y, Wang Z, Wang G, Wu H, Zhang L, Wei J, Zhao Y, Zhao J. Che F, et al. Among authors: wu h. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 Feb 10;38(2):150-153. doi: 10.3760/cma.j.cn511374-20200415-00271. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021. PMID: 33565069 Chinese.

7

A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy.

Zhang L, Wang M, Zhu Z, Ding C, Chen S, Wu H, Yang Y, Che F, Li Q, Li H. Zhang L, et al. Among authors: wu h. Int J Nanomedicine. 2021 May 10;16:3217-3240. doi: 10.2147/IJN.S302450. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34007175 Free PMC article.

8

Novel Compound Heterozygous Pathogenic Variants in SUOX Cause Isolated Sulfite Oxidase Deficiency in a Chinese Han Family.

Zhao J, An Y, Jiang H, Wu H, Che F, Yang Y. Zhao J, et al. Among authors: wu h. Front Genet. 2021 May 7;12:607085. doi: 10.3389/fgene.2021.607085. eCollection 2021. Front Genet. 2021. PMID: 34025712 Free PMC article.

9

Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy.

Wu H, Zhang L, Zhu Z, Ding C, Chen S, Liu R, Fan H, Chen Y, Li H. Wu H, et al. Drug Deliv. 2021 Dec;28(1):1166-1178. doi: 10.1080/10717544.2021.1934191. Drug Deliv. 2021. PMID: 34121564 Free PMC article.

10

A GD2-aptamer-mediated, self-assembling nanomedicine for targeted multiple treatments in neuroblastoma theranostics.

Zhang L, Wang M, Zhu Z, Chen S, Wu H, Yang Y, Che F, Li Q, Li H. Zhang L, et al. Among authors: wu h. Mol Ther Nucleic Acids. 2021 Aug 26;26:732-748. doi: 10.1016/j.omtn.2021.08.021. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34703655 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,762 results

Search Page

Filters